Given Imaging share price spikes as it mulls sale
This article was originally published in Clinica
Israeli capsule developer Given Imaging has said that it is considering putting itself up for sale, leading to a jump in its share price on the Nasdaq Global Select market. The firm's stock was trading as high as $15.50 on 17 October, the day it put out the statement, eventually closing at $15.27, up 2% from the previous day.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.